Sign in
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Clinical Course and Outcomes at 3 Years After Severe Fungal Endophthalmitis in 14 Eyes Following Contaminated Bevacizumab Intravitreal Injection
Mallika Goyal, MD
2018
Cooling Anesthesia for Intravitreal Injection With a Novel Device: Results of the Prospective COOL-2 Study
Daniel L Chao, MD, PhD
2020
Category: Pharmacology